Salvianolic acid B inhibits ERK and p38 MAPK signaling in TGF-Β1-stimulated human hepatic stellate cell line (LX-2) via distinct pathways

41Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Salvianolic acid B (SA-B) is water-soluble component of Radix Salvia miltiorrhiza. The previous work indicated that SA-B can inhibit MAPK and Smad signaling in activated hepatic stellate cells (HSCs) to perform anti-fibrotic activity Lv et al. 2010. However, some studies have shown that there is cross-talk between MAPK and Smad in certain cell types. Thus, the anti-fibrotic action of SA-B may be through the cross-talk. In order to clarify the mechanism of SA-B further, we knocked down Smad in LX-2 cells (SRV4) via RNAi, and then added TGF-1, and PD98059 or SB203580 and SA-B. The levels of p-MEK and p-p38 were inhibited by SA-B in SRV4 independent of TGFΒ-1. The expression of Col I and -SMA in SRV4 could be reduced by SA-B independent TGFΒ-1. SB203580 had not significant effect on p-MEK in SRV4 stimulated by TGFΒ-1. The levels of p-MEK in SRV4 were not increased significantly after TGFΒ-1 stimulation. PD98059 had no effect on the levels of p-p38 in SRV4 irrespective of TGF-1. In conclusion, SA-B inhibits the synthesis of Col I in LX-2 cells independent of TGF-1 stimulation, and the anti-fibrotic effect of SA-B is due to direct inhibition of p38 signaling and inhibition the cross-talk of Smad to ERK signaling.

Cite

CITATION STYLE

APA

Xu, L., & Lv, Z. (2012). Salvianolic acid B inhibits ERK and p38 MAPK signaling in TGF-Β1-stimulated human hepatic stellate cell line (LX-2) via distinct pathways. Evidence-Based Complementary and Alternative Medicine, 2012. https://doi.org/10.1155/2012/960128

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free